Navigating the intricate in-vivo journey of lipid nanoparticles tailored for the targeted delivery of RNA therapeutics: a quality-by-design approach.

RNA therapeutics, such as mRNA, siRNA, and CRISPR-Cas9, present exciting avenues for treating diverse diseases. However, their potential is commonly hindered by vulnerability to degradation and poor cellular uptake, requiring effective delivery systems. Lipid nanoparticles (LNPs) have emerged as a leading choice for in vivo RNA delivery, offering protection against degradation, enhanced cellular uptake, and facilitation of endosomal escape.

Nanoporous MIL-101(Cr) as a sensing layer coated on a quartz crystal microbalance (QCM) nanosensor to detect volatile organic compounds (VOCs).

The application of metal-organic frameworks (MOFs) as a sensing layer has been attracting great interest over the last decade, due to their high porosity and tunability, which provides a large surface area and active sites for trapping or binding target molecules. MIL-101(Cr) is selected as a good candidate from the MOFs family to fabricate a quartz crystal microbalance (QCM) nanosensor for the detection of volatile organic compound (VOC) vapors. The structural and chemical properties of synthesized MIL-101(Cr) are investigated by X-ray diffraction (XRD), Fourier-transfer infrared spectroscopy (FTIR) and scanning electron microscopy (SEM) and so on.